Drug research

Sham Comparator

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKNCT06990399	KOD	Phase 3	Recruiting	2027-04Estimated
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLENCT06996080	KOD	Phase 3	Recruiting	2027-02Estimated
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart FailureNCT02032004	Mesoblast, Inc.	Phase 3	Completed	2020-01-30Actual
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNCT05099770	Prokidney	Phase 3	Active not recruiting	2029-12Estimated
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeNCT06872125	STOK	Phase 3	Recruiting	2027-03Estimated

KODRecruitingPrimary completion: 2027-04 · Estimated

Trial details

KODRecruitingPrimary completion: 2027-02 · Estimated

Trial details

Mesoblast, Inc.CompletedPrimary completion: 2020-01-30 · Actual

Trial details

ProkidneyActive not recruitingPrimary completion: 2029-12 · Estimated

Trial details

STOKRecruitingPrimary completion: 2027-03 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.